CLINICAL TRIALS PROFILE FOR TRALEMENT
✉ Email this page to a colleague
All Clinical Trials for TRALEMENT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05661682 ↗ | Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition | Not yet recruiting | American Regent, Inc. | Phase 4 | 2022-12-31 | Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in adult patients requiring long-term parenteral nutrition. |
NCT05677126 ↗ | Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients >3 to 17 Years of Age Requiring Long-term Parenteral Nutrition | Not yet recruiting | American Regent, Inc. | Phase 4 | 2022-12-31 | Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in pediatric patients >3 to 17 years of age requiring long-term parenteral nutrition. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRALEMENT
Condition Name
Clinical Trial Progress for TRALEMENT
Clinical Trial Phase
Clinical Trial Sponsors for TRALEMENT
Sponsor Name